Licofelone - Novel Analgesic and Anti-Inflammatory Agent for Osteoarthritis
Key Data:
Drug (Brand / Generic)
Licofelone (ML3000)
Company / Licensee
Merckle GmbH and EuroAlliance partners Alfa Wassermann and Lacer
Therapy Class
Dual COX/LOX inhibitor
Product Description
Inhibits the action of COX and 5-LOX enzymes
Current Indication
Treatment of pain and inflammation associated with OA
Market Sector
CNS - pain
Development Status
Phase III
